Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
02/06/2026 15:28
BRIEF-Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization June 2 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:
BLISS GVS PHARMA LTD - RECEIVED AN INSPECTION CLOSURE REPORT FROM WORLD HEALTH ORGANIZATION
BLISS GVS PHARMA - PALGHAR FACILITY HAS BEEN CONFIRMED TO BE IN COMPLIANCE WITH GOOD MANUFACTURING PRACTICES
Source text: ID:nBSE5nDDM8
Further company coverage: BLIS.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees